Tu Shun, Guo Shu-Juan, Chen Chien-Sheng, Liu Cheng-Xi, Jiang He-Wei, Ge Feng, Deng Jiao-Yu, Zhou Yi-Ming, Czajkowsky Daniel M, Li Yang, Qi Bang-Ruo, Ahn Young-Hoon, Cole Philip A, Zhu Heng, Tao Sheng-Ce
Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
State Key Laboratory of Oncogenes and Related Genes, Shanghai, China.
Elife. 2015 Dec 30;4:e05322. doi: 10.7554/eLife.05322.
Reversible lysine acetylation is one of the most important protein posttranslational modifications that plays essential roles in both prokaryotes and eukaryotes. However, only a few lysine deacetylases (KDACs) have been identified in prokaryotes, perhaps in part due to their limited sequence homology. Herein, we developed a 'clip-chip' strategy to enable unbiased, activity-based discovery of novel KDACs in the Escherichia coli proteome. In-depth biochemical characterization confirmed that YcgC is a serine hydrolase involving Ser200 as the catalytic nucleophile for lysine deacetylation and does not use NAD(+) or Zn(2+) like other established KDACs. Further, in vivo characterization demonstrated that YcgC regulates transcription by catalyzing deacetylation of Lys52 and Lys62 of a transcriptional repressor RutR. Importantly, YcgC targets a distinct set of substrates from the only known E. coli KDAC CobB. Analysis of YcgC's bacterial homologs confirmed that they also exhibit KDAC activity. YcgC thus represents a novel family of prokaryotic KDACs.
可逆赖氨酸乙酰化是最重要的蛋白质翻译后修饰之一,在原核生物和真核生物中都发挥着重要作用。然而,在原核生物中仅鉴定出少数赖氨酸脱乙酰酶(KDAC),这可能部分归因于它们有限的序列同源性。在此,我们开发了一种“夹芯片”策略,以在大肠杆菌蛋白质组中实现基于活性的新型KDAC的无偏发现。深入的生化特性分析证实,YcgC是一种丝氨酸水解酶,以Ser200作为赖氨酸脱乙酰化的催化亲核试剂,并且不像其他已确定的KDAC那样使用NAD(+)或Zn(2+)。此外,体内特性分析表明,YcgC通过催化转录阻遏物RutR的Lys52和Lys62去乙酰化来调节转录。重要的是,YcgC靶向一组与唯一已知的大肠杆菌KDAC CobB不同的底物。对YcgC的细菌同源物的分析证实,它们也表现出KDAC活性。因此,YcgC代表了一个新型的原核KDAC家族。